Heterogeneity of cellular proliferation within transitional cell carcinoma: Correlation of protein kinase C alpha/betal expression and activity

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 7, 2006, Pages 795-806

  Aaltonen, Vesa ^a   Koivunen, Jussi ^a,c   Laato, Matti ^b   Peltonen, Juha ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c KAINUU CENTRAL HOSPITAL   (Finland)

Author keywords

Alpha; Betal; Bladder; Carcinoma; Expression; Proliferation; Protein kinase C

Indexed keywords

ISOENZYME; KI 67 ANTIGEN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL COUNT; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOPLASM; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SUBSTRATE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; UROTHELIUM; WESTERN BLOTTING;

CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33745347956     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.5A6839.2006     Document Type: Article

References (52)

1. Ainsworth PD, Winstanley JH, Pearson JM, Bishop HM, Garrod DR (2004) Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma. Eur J Cancer 40:2269-2273
2. al-Mazidi HA, Kleine LP, Franks DJ (1998) The presence of an unusual PKC isozyme profile in rat liver cells. Biochem Cell Biol 76:73-82
3. Aydin A, Ucak R, Karakok M, Guldur ME, Kocer NE (2002) Vascular plexus is a differentiation criterion for muscularis mucosa from muscularis propria in small biopsies and transurethral resection materials of urinary bladder? Int Urol Nephrol 34:315-319
4. Barr LF, Mabry M, Nelkin BD, Tyler G, May WS, Baylin SB (1991) c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation. Cancer Res 51:5514-5519
5. Bastiaens PI, Jovin TM (1996) Microspectroscopic imaging tracks the intracellular processing of a signal transduction protein: fluorescent-labeled protein kinase C beta I. Proc Natl Acad Sci USA 93:8407-8412
6. Biswas DK, Martin KJ, McAlister C, Crux AP, Graner E, Dai SC, Pardee AB (2003) Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res 63:290-295
7. Blanes A, Rubio J, Martinez A, Wolfe FIJ, Diaz-Cano SJ (2002) Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. Am J Clin Pathol 118:93-100
8. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, et al. (1993) Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. J Biol Chem 268:658-664
9. Blumberg PM, Jaken S, Konig B, Sharkey NA, Leach KL, Jeng AY, Yeh F. (1984) Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands. Biochem Pharmacol 33:933-940
10. Brown JL, Russell PJ, Philips J, Wotherspoon J, Raghavan D (1990) Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer 61:369-376
11. Burgering BM, de Vries-Smits AM, Medema RH, van Weeren PC, Tertoolen LG, Bos JL (1993) Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways. Mol Cell Biol 13:7248-7256
12. Cogram P, Hynes A, Dunlevy LP, Greene ND, Copp AJ (2004) Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol. Hum Mol Genet 13:7-14
13. Delage S, Chastre E, Empereur S, Wicek D, Veissiere D, Capeau J, Gespach C, et al. (1993) Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Cancer Res 53:2762-2770
14. Diaz-Cano SJ, Blanes A, Rubio J, Matilla A, Wolfe HJ (2000) Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab Invest 80:279-289
15. Fournier DB, Chisamore M, Lurain JR, Rademaker AW, Jordan VC, Tonetti DA (2001) Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Gynecol Oncol 81:366-372
16. Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP (2001) Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 61:1375-1381
17. Goode N, Hughes K, Woodgett JR, Parker PJ (1992) Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem 267:16878-16882
18. Jiang XH, Tu SP, Cui JT, Lin MC, Xia HH, Wong WM, Chan AO, et al. (2004) Antisense targeting protein kinase C alpha and beta I inhibits gastric carcinogenesis. Cancer Res 64:5787-5794
19. Kerfoot C, Huang W, Rotenberg SA (2004) Immunohistochemical analysis of advanced human breast carcinomas reveals down-regulation of protein kinase C alpha. J Histochem Cytochem 52:419-422
20. Koivunen J, Aaltonen V, Koskela S, Lehenkari P, Laato M, Peltonen J (2004) Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Res 64:5693-5701
21. Koivunen J, Aaltonen V, Peltonen J (2006) Protein kinase C (PKC) family in cancer progression. Cancer Lett 235:1-10
22. Kong C, Zhu Y, Liu D, Yu M, Li S, Li Z, Sun Z, et al. (2005) Role of protein kinase C-alpha in superficial bladder carcinoma recurrence. Urology 65:1228-1232
23. Koren R, Ben Meir D, Langzam L, Dekel Y, Konichezky M, Baniel J, Livne PM, et al. (2004) Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate. Oncol Rep 11:321-326
24. Koren R, Langzam L, Paz A, Livne PM, Gal R, Sampson SR (2000) Protein kinase C (PKC) isoenzymes immunohistochemistry in lymph node revealing solution-fixed, paraffin-embedded bladder tumors. Appl Immunohistochem Mol Morphol 8:166-171
25. La Porta CA, Tessitore L, Comolli R (1997) Changes in protein kinase C alpha, delta and in nuclear beta isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat. Carcinogenesis 18:715-719
26. Libien J, Sacktor TC, Kass IS (2005) Magnesium blocks the loss of protein kinase C, leads to a transient translocation of PKC(alpha) and PKC(epsilon), and improves recovery after anoxia in rat hippocampal slices. Brain Res Mol Brain Res 136:104-111
27. Limas C, Bigler A, Bair R, Bernhart P, Reddy P (1993) Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions. J Clin Pathol 46:159-165
28. Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA (1998) Activation of protein kinase C triggers its ubiquitinatton and degradation. Mol Cell Biol 18:839-845
29. Mandil R, Ashkenazi E, Blass M, Kronfeld I, Kazimirsky G, Rosenthal G, Umansky F, et al. (2001) Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res 61:4612-4619
30. Martinez-Gimeno C, Diaz-Meco MT, Dominguez I, Moscat J (1995) Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: epsilon PKC, a novel prognostic factor for relapse and survival. Head Neck 17:516-525
31. Neill GW, Ghali LR, Green JL, Ikram MS, Philpott MP, Quinn AG (2003) Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. Cancer Res 63:4692-4697
32. Nishikawa K, Toker A, Johannes FJ, Songyang Z, Cantley LC (1997) Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 272:952-960
33. Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614
34. Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496
35. Paolucci L, Rozengurt E (1999) Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C. Cancer Res 59:572-577
36. Pfaff IL, Wagner HJ, Vallon V (1999) Immunolocalization of protein kinase C isoenzymes alpha, beta1 and betaII in rat kidney. J Am Soc Nephrol 10:1861-1873
37. Prevostel C, Alvaro V, de Boisvilliers F, Martin A, Jaffiol C, Joubert D (1995) The natural protein kinase C alpha mutant is present in human thyroid neoplasms. Oncogene 11:669-674
38. Raghunath A, Ling M, Larsson C (2003) The catalytic domain limits the translocation of protein kinase C alpha in response to increases in Ca2+ and diacylglycerol. Biochem J 370:901-912
39. Redling S, Pfaff IL, Leitges M, Vallon V (2004) Immunolocalization of protein kinase C isoenzymes alpha, beta I, beta II, delta, and epsilon in mouse kidney. Am J Physiol Renal Physiol 287: F289-F298
40. Ro JY, Ayala AG, el-Naggar A (1987) Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 11:668-673
41. Sharkey NA, Leach KL, Blumberg PM (1984) Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc Natl Acad Sci USA 81:607-610
42. Shirakawa F, Mizel SB (1989) In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 9:2424-2430
43. Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA (1998) Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 52:1009-1013
44. Stearns V, Coop A, Singh B, Gallagher A, Yamauchi H, Lieberman R, Pennanen M, et al. (2004) A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clin Cancer Res 10:7583-7591
45. Svensson K, Zeidman R, Troller U, Schultz A, Larsson C (2000) Protein kinase C beta1 is implicated in the regulation of neuroblastoma cell growth and proliferation. Cell Growth Differ 11:641-648
46. Tortora G, Ciardiello F (2003) Antisense strategies targeting protein kinase C: preclinical and clinical development. Semin Oncol 30:26-31
47. Tsai JH, Hsieh YS, Kuo SJ, Chen ST, Yu SY, Huang CY, Chang AC, et al. (2000) Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma. Cancer Lett 161:171-175
48. Varga A, Czifra G, Tallai B, Nemeth T, Kovacs I, Kovacs L, Biro T (2004) Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. Eur Urol 46:462-465
49. Voorter C, Joos S, Bringuier PP, Vallinga M, Poddighe P, Schalken J, du Manoir S, et al. (1995) Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 146:1341-1354
50. Wetsel WC, Khan WA, Merchenthaler I, Rivera H, Halpern AE, Phung HM, Negro-Vilar A, et al. (1992) Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 117:121-133
51. Zhan M, Yu D, Liu J, Hannay J, Pollock RE (2005) Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation. J Biol Chem 280:4825-4833
52. Zugaza JL, Sinnett-Smith J, Van Lint J, Rozengurt E (1996) Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J 15:6220-6230